Physician profile
William B Macaulay
NPI 1154347888
$31,074.34
in general payments reported to CMS, 2019-2025
12 companies · $6,557 in 2025
The $6,557 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2020: $34.50 · 2021: $150 · 2022: $607 · 2023: $12K · 2024: $11K · 2025: $6,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $28K · Food and Beverage: $1,269 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $27,750.45 |
| Food and Beverage | $1,268.61 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $27,750.45 | 2023-2025 | Djo Surgical |
| Exactech, INC. | $1,307.65 | 2022-2024 | |
| Synthes Gmbh | $750.00 | 2024 | |
| Stryker Corporation | $367.12 | 2019 | |
| Smith+Nephew, INC. | $181.38 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $180.51 | 2025 | G7 |
| Baudax Bio INC. | $150.00 | 2021 | |
| Medical Device Business Services, INC. | $147.20 | 2024 | Attune |
| Lilly USA, LLC | $125.10 | 2022 | |
| Depuy Synthes Sales INC. | $59.51 | 2024 | Velys |
| Pacira Pharmaceuticals Incorporated | $39.18 | 2025 | Iovera |
| Solventum Corporation | $16.24 | 2024 | Prevena, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Macaulay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.